Redcare Pharmacy N.V. · ISIN: NL0012044747 · EQS - Company News

strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.

Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. Total Group sales growth 21% in Q3 to EUR 575M and 34% year to date to EUR 1.7bn after nine months. Non-Rx sales growth 20% in Q3 to EUR 383M (9M growth 20% to EUR 1.2bn); Rx sales growth 23% in Q3 to EUR 191M (9M increase 80% to EUR 518M). Rx sales in Germany alone grew 81% in Q3 to 69M and reached EUR 157M year to date.  The momentum fu...

XETR:RDC Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Redcare Pharmacy N.V.

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (11)
Short Selling (DE) (48)
Short Selling (UK) (0)
05 November 2024 06:30AM
strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
NL0012044747
Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. Total Group sales growth 21% in Q3 to EUR 575M and 34% year to date to EUR 1.7bn after nine months. Non-Rx sales growth 20% in Q3 to EUR 383M (9M growth 20% to EUR 1.2bn); Rx sales growth 23%...
Redcare Pharmacy N.V.
About the publication
03 October 2024 10:01PM
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
NL0012044747
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics. Q3 total Group sales up 21% year over year to EUR 574M and year to date 34% to EUR 1.7bn; non-Rx sales growth 20% year over year to EUR 383M and also 20% year to date to EUR 1.2bn. Active cus...
Redcare Pharmacy N.V.
About the publication
03 October 2024 09:57PM
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
NL0012044747
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated. Sevenum, the Netherlands, 3 October 2024. The Management Board of Redcare Pharmacy has decided to intensify marketing investments for its e-Rx business in Ger...
Redcare Pharmacy N.V.
About the publication
30 July 2024 06:30AM
Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin. 
NL0012044747
Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.  Total sales of over EUR 1.1 bn after six months, up 42%, with Q2 year-over-year growth of 34% to EUR 561M. H1 non-Rx sales of EUR 795M (+20%); EUR 391M in Q2 (+21%). Total Rx sales of EUR...
Redcare Pharmacy N.V.
About the publication
04 July 2024 06:45AM
Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2.
NL0012044747
Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2. Total sales reached EUR 560M in Q2, up 33% year over year. Non-Rx sales totaled EUR 390M, steady continuation of fast growth, up 21% year over year. Rx sales increased to EUR 50M in Germany, 37% growth in Q2 year over year, while CardLink was la...
Redcare Pharmacy N.V.
About the publication
06 May 2024 04:57PM
the convenient way to redeem e-prescriptions from anywhere.
NL0012044747
Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere. Fully digital redemption method via eGK health card and smartphone. Secure, easy and comfortable way to redeem e-prescriptions. Technically integrated within Redcare’s Shop Apotheke mobile app in Germany. Sevenum, the ...
Redcare Pharmacy N.V.
About the publication
25 April 2024 06:30AM
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
NL0012044747
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany. Group sales of EUR 560M in Q1, up 51% from prior year. Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns. Adj. EBITDA ma...
Redcare Pharmacy N.V.
About the publication
23 April 2024 03:59PM
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
NL0012044747
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Fully digital redemption method to be integrated in Redcare’s Shop Apotheke mobile app in Germany. Expected to be available for customers by early May. Redcare ideally positioned to serve e-Rx customers in the multi-billion-euro German prescription market. Sevenum, the Neth...
Redcare Pharmacy N.V.
About the publication
23 April 2024 03:56PM
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
NL0012044747
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using thei...
Redcare Pharmacy N.V.
About the publication
18 April 2024 09:00AM
Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
NL0012044747
Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board. Sevenum, the Netherlands, 18 April, 2024. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of Dirk Brüse ...
Redcare Pharmacy N.V.
About the publication
04 April 2024 06:45AM
Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
NL0012044747
Strong start of the year for Redcare Pharmacy, double-digit sales growth continues. Total sales growth 51% year over year to EUR 560M in Q1 and 19% excluding MediService. Non-Rx sales growth 20% to EUR 404M. Active customer base expanded to 11.2M, up 0.4M in Q1 and 1.5M year over year. Net promoter score remained unabatedly high around 70. Fi...
Redcare Pharmacy N.V.
About the publication
05 March 2024 06:30AM
growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
NL0012044747
Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements. Total Group sales EUR 1.8 bn, up 49% vs. prior year. Non-Rx sales EUR 1.3 bn, up 25% vs. prior year. Adj. EBITDA margin 3% for full year 2023, +3.7pp vs. 2022, with major improvements in both DACH an...
Redcare Pharmacy N.V.
About the publication
04 March 2024 07:04PM
Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
NL0012044747
Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO). Dirk Brüse and Lode Fastré, both long-standing managers at Redcare Pharmacy, are to succeed Stephan Weber and Marc Fischer as CCO and CIO. Board members and founders see the ideal time for the leadership...
Redcare Pharmacy N.V.
About the publication
04 March 2024 07:02PM
Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
NL0012044747
Disclosure of inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014   Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024. Sevenum, 4 March 2024. The Supervisory Board of Redcare Pharmacy today has agreed to the e...
Redcare Pharmacy N.V.
About the publication
10 January 2024 06:45AM
Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
NL0012044747
Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.  Q4 total sales EUR 531M, year-over-year growth 62%, excluding MediService 23%. Full year total sales EUR 1.8bn vs. guidance of EUR 1.7-1.8bn, a growth of 49%. Excluding MediService, growth was 24%. Non-Rx sales grew 23% ...
Redcare Pharmacy N.V.
About the publication
31 October 2023 06:30AM
continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.
NL0012044747
Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year. Group sales up 67% to EUR 476M in Q3 (9M up 45% to EUR 1.3bn). Non-Rx sales growth 27% in Q3 to EUR 319M (9M up 26% to EUR 979M). MediService performing on plan; full-year outlook confirmed. Adj. EBITDA margin 3.2% in Q3 (9M...
Redcare Pharmacy N.V.
About the publication
05 October 2023 06:45AM
Redcare Pharmacy continues to successfully grow fast in all its markets.
NL0012044747
Redcare Pharmacy continues to successfully grow fast in all its markets. Total sales growth 67% in Q3, to EUR 475M. Year-to-date total sales growth 45%, to EUR 1.3bn. Organic growth (i.e. excluding sales of MediService) 26% to EUR 358M in Q3 and 24% to EUR 1.1bn year to date. Non-Rx growth 27% in Q3 (to EUR 319M) and year to date 26% (to EUR 97...
Redcare Pharmacy N.V.
About the publication
01 August 2023 06:30AM
While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
NL0012044747
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance. Total sales up 46% in Q2 to EUR 420M and by 34% in H1 to EUR 792M. Excluding MediService AG (consolidated since mid-May), sales up 25% in Q2 and 24% in H1. Non-Rx growth 27% in ...
Redcare Pharmacy N.V.
About the publication
01 August 2023 06:30AM
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
NL0012044747
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance. Total sales up 46% in Q2 to EUR 420M and by 34% in H1 to EUR 792M. Excluding MediService AG (consolidated since mid-May), sales up 25% in Q2 and 24% in H1. Non-Rx growth 27% in ...
Redcare Pharmacy N.V.
About the publication
06 July 2023 06:45AM
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
NL0012044747
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth. Total sales growth 47% to EUR 421M in Q2. Year to date sales EUR 793M, a growth of 34%. Excluding the sales of MediService AG (transaction with Galenica AG completed mid-May), sales growth was 26% to EUR 361M in Q2 and 24% to EUR 733M year to date, dri...
Redcare Pharmacy N.V.
About the publication
06 July 2023 06:45AM
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
NL0012044747
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth. Total sales growth 47% to EUR 421M in Q2. Year to date sales EUR 793M, a growth of 34%. Excluding the sales of MediService AG (transaction with Galenica AG completed mid-May), sales growth was 26% to EUR 361M in Q2 and 24% to EUR 733M year to date, dri...
Redcare Pharmacy N.V.
About the publication
13 June 2023 09:32AM
Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
NL0012044747
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leadinge-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official. With today’s event, Europe’s largest one-stop pharmacy takes another step ...
Redcare Pharmacy N.V.
About the publication
13 June 2023 09:32AM
Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
NL0012044747
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leadinge-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official. With today’s event, Europe’s largest one-stop pharmacy takes another step ...
Redcare Pharmacy N.V.
About the publication
06 June 2023 09:15AM
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
NL0012044747
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX. Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd. Effective 19 June 2023, SHOP APOTHEKE EUROPE will be among the 50 largest listed companie...
Redcare Pharmacy N.V.
About the publication
06 June 2023 09:15AM
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
NL0012044747
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX. Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd. Effective 19 June 2023, SHOP APOTHEKE EUROPE will be among the 50 largest listed companie...
Redcare Pharmacy N.V.
About the publication
22 May 2023 10:59PM
Termination of voting pool agreement.
NL0012044747
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement. Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rig...
SHOP APOTHEKE EUROPE N.V.
About the publication
22 May 2023 10:59PM
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
NL0012044747
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement. Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rig...
SHOP APOTHEKE EUROPE N.V.
About the publication
11 May 2023 07:18PM
SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
NL0012044747
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland. Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for the joint venture between SHOP APOTHEKE EUROPE and Galenica today. In late March 2023, SHOP APOTHEKE EUROPE, Europe’s ...
SHOP APOTHEKE EUROPE N.V.
About the publication
11 May 2023 07:18PM
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
NL0012044747
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland. Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for the joint venture between SHOP APOTHEKE EUROPE and Galenica today. In late March 2023, SHOP APOTHEKE EUROPE, Europe’s ...
SHOP APOTHEKE EUROPE N.V.
About the publication
11 May 2023 07:14PM
Antitrust clearances for joint venture granted
NL0012044747
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss ma...
SHOP APOTHEKE EUROPE N.V.
About the publication
11 May 2023 07:14PM
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
NL0012044747
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss ma...
SHOP APOTHEKE EUROPE N.V.
About the publication
02 May 2023 06:45AM
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
NL0012044747
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.   Total sales up 22% to EUR 372 million. Non-Rx sales growth 23%; outpacing the full-year guidance of 10 to 20%. Adj. EBITDA margin 2.4%, 3.8 pp better than Q1 2022; upper part of the full-year guidance of 0.5 to 2.5%. Comfortably on tra...
SHOP APOTHEKE EUROPE N.V.
About the publication
02 May 2023 06:45AM
STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
NL0012044747
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.   Total sales up 22% to EUR 372 million. Non-Rx sales growth 23%; outpacing the full-year guidance of 10 to 20%. Adj. EBITDA margin 2.4%, 3.8 pp better than Q1 2022; upper part of the full-year guidance of 0.5 to 2.5%. Comfortably on tra...
SHOP APOTHEKE EUROPE N.V.
About the publication
27 April 2023 10:11AM
Approval of New CEO and Change of Corporate Name.
NL0012044747
Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name. Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. was a resounding success - investors voted with an absolute majority in favour of both the appointment of Olaf Heinrich ...
SHOP APOTHEKE EUROPE N.V.
About the publication
27 April 2023 10:11AM
Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
NL0012044747
Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name. Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. was a resounding success - investors voted with an absolute majority in favour of both the appointment of Olaf Heinrich ...
SHOP APOTHEKE EUROPE N.V.
About the publication
05 April 2023 06:45AM
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
NL0012044747
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021. Q1 total sales up 22% year over year to EUR 371 million. Non-Rx sales growth 23%. Customer satisfaction remains very high with NPS above 70. Continued fast growth of customer base to 9.7 million; active customer base up 0.4 million in Q1 and 1.4 million year over ...
SHOP APOTHEKE EUROPE N.V.
About the publication
05 April 2023 06:45AM
VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
NL0012044747
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021. Q1 total sales up 22% year over year to EUR 371 million. Non-Rx sales growth 23%. Customer satisfaction remains very high with NPS above 70. Continued fast growth of customer base to 9.7 million; active customer base up 0.4 million in Q1 and 1.4 million year over ...
SHOP APOTHEKE EUROPE N.V.
About the publication
30 March 2023 06:59AM
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
NL0012044747
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.   Sevenum, the Netherlands, 30 March 2023. As part of a strategic partnership, Europe's leading e-pharmacy SHOP APOTHEKE EUROPE N.V. and GALENICA AG, the leading integrated healthcare provider in Switzerland, are ...
SHOP APOTHEKE EUROPE N.V.
About the publication
30 March 2023 06:59AM
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
NL0012044747
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.   Sevenum, the Netherlands, 30 March 2023. As part of a strategic partnership, Europe's leading e-pharmacy SHOP APOTHEKE EUROPE N.V. and GALENICA AG, the leading integrated healthcare provider in Switzerland, are ...
SHOP APOTHEKE EUROPE N.V.
About the publication
30 March 2023 06:58AM
​​​​​​​SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.
NL0012044747
SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.   Sevenum, 30 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE") and the internationally active Swiss integrated healthcare service provider GALENICA AG, operating in the segme...
SHOP APOTHEKE EUROPE N.V.
About the publication
30 March 2023 06:58AM
​​​​​​​SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.
NL0012044747
SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.   Sevenum, 30 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE") and the internationally active Swiss integrated healthcare service provider GALENICA AG, operating in the segme...
SHOP APOTHEKE EUROPE N.V.
About the publication
15 March 2023 06:34PM
SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023
NL0012044747
NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023 Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the "Company") has today publis...
SHOP APOTHEKE EUROPE N.V.
About the publication
15 March 2023 06:34PM
SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023
NL0012044747
NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023 Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the "Company") has today publis...
SHOP APOTHEKE EUROPE N.V.
About the publication
15 March 2023 06:33PM
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.
NL0012044747
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO. Sevenum, the Netherlands, 15 March 2023. The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM. In this position, he will succeed Stefan Feltens, who will retire after the expiration of his current 4-year ter...
SHOP APOTHEKE EUROPE N.V.
About the publication
15 March 2023 06:33PM
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.
NL0012044747
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO. Sevenum, the Netherlands, 15 March 2023. The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM. In this position, he will succeed Stefan Feltens, who will retire after the expiration of his current 4-year ter...
SHOP APOTHEKE EUROPE N.V.
About the publication
15 March 2023 06:30PM
Olaf Heinrich shall become the new CEO
NL0012044747
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. (SAE.DE), hereby announces that the supervisory board resolved today to propose Mr. Olaf Heinrich for election as member of the managing board and chairman of the managing board of the company at the next annual general meeting, whic...
SHOP APOTHEKE EUROPE N.V.
About the publication
15 March 2023 06:30PM
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO
NL0012044747
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. (SAE.DE), hereby announces that the supervisory board resolved today to propose Mr. Olaf Heinrich for election as member of the managing board and chairman of the managing board of the company at the next annual general meeting, whic...
SHOP APOTHEKE EUROPE N.V.
About the publication
07 March 2023 06:30AM
SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR.
NL0012044747
SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR. Group sales up 14% to EUR 1.2 billion in 2022. Full year guidance provided at the start of 2022 met in all elements; non-Rx growth 17.2%, adj. EBITDA margin -0.3%. Adj. EBITDA margin in Q4 0.3% (for ongoing operations 0.8...
SHOP APOTHEKE EUROPE N.V.
About the publication
More Redcare Pharmacy N.V. related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 11 21st November 2024 Eenhorst, Jasper DD
Short Seller (DE) 48 18th November 2024 Qube Research & Technologies Limited SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN